about company

for investors

research & development

intellectual property

contacts

Ĩesky

Azacycles Nanobot Technology

Receptor Shield Technology

Azacycles Virus Trap Technology

Azacycles Nanobot Technology
There are three principal directions of present research & development in the Azacycles company. Each of them represents independent and individual way to independent technological knowledge and technological intellectual property rights, but their outgoings are strongly mutually utilisable like a kit of blocks for a formation of higly effective and revolutionary targeted pharmaceuticals and targeted drugs of totally new concepts:
Nanobot Azacycles Virus Trap Technology Receptor Shield Technology
The Azacycles Nanobot technology represents hollow highly hydrophilic nano-spherical particles with polysaccharide fully covalent skeletons of exceptional parameters. They are rare especially for their variability, stability of encapsulated content, available methods of fulfillment, a natural possibility to differently modify inner and outer wall of the skeleton and for a handling of its encapsulated content liberation in organism, which is controlled by integrated nano-time-lock in skeleton of the nano-spheres. The nano-spheres are like a parent saccharides fully degradable into native compounds in organism and therefore does not stress organism by xenobiotics. This technology is based on three-generation concept, for another information please see Azacycles' road map or if you are interested in from serious reasons, please register for access to restricted area of this websites.
The Azacycles Virus Trap technology represents radically and revolutionarily new concept of antiviral agents or drugs for warfare with viruses. The technology is rare for its entire independecy on surface epitopes of viruses, does not interfere into their actioning pathways and also very rare is the fact that all metabolites from the compounds of the technology are native compounds in organism and therefore does not stress organism by xenobiotics. It is utilisable for retroviruses as well as DNA viruses of all classes. The Azacycles company is going to tiny change the concepf for ability of this technology to action in area of bacteria's therapy. The technology is based on Azacycles Nanobot technology 2nd Generation outgoings. For another information please see Azacycles' road map or if you are interested in from serious reasons, please register for access to restricted area of this websites.
The Azacycles Receptor Shield technology represents new concept of therapy of cancer stem cells, thus e.g. cancer metastazes, and also very utilisable concept of therapy with stem cells, e.g. in tissue neoplastics. By the technology it is possible to design and to produce depot forms of peptide hormones, of signal proteins or depot forms of peptide growth factors and of course very strongly anti-cancer-stem-cell actioning pharmaceuticals and future anticancer drugs. In this last case there is interesting the technology does not interfere into life-cycle pathways of the cancer stem cells from inside of the cells. The technology is based on Azacycles Nanobot technology 1st and 2nd Generation outgoings. For another information please see Azacycles' road map or if you are interested in from serious reasons, please register for access to restricted area of this websites.
The Azacycles' company R&D road map: for download please click here.
© 2012 Azacycles s.r.o.